RESULTS FOR : 'Partnering'
Showing 1 to 5 of 5 results |    
Keyword Search
Show#
Show#
Results Category/Section
The Art of Collaboration - Partnering and Licensing at Novartis

Partnering and licensing have become paramount in a pharmaceutical industry that is under inordinate pressure to fill pipelines and increase the number of approved new molecular entities. This article discusses how Novartis has gone about addressing this issue.

Partnering with the right CRO is a winning strategy for companies big and small

The Bio-Pharma business model is undergoing radical changes. Over the last two decades, we have seen the biopharmaceutical industry gradually become more willing to look externally and embrace the concept of outsourcing as it looks for new sources of discovery and innovation.

Academic Ingenuity and Corporate Partnerships: New models in human health ventures bring value to all

Many disapprove of science faculty at American universities procuring corporate ventures that support research, instead of primarily functioning as an instructor, mentor and basic researcher. This perception is most evident surrounding biomedical research at public universities. In addition, some object that corporate-funded projects involve student research.

Pharmaceutical Industry R&D Partnering Strategies

With a sustained rate of more than 250 R&D partnering deals each year many valuable lessons are being learned. Although there is no exact 'formula for success' there are many 'success factors' that can be utilised to reduce the risk of failure.

Controlling the risks of PARTNERING

The barriers to establishing an equitable partnership between biotechs and big pharma are high and many partnerships, once established, do not deliver the tangible and non-tangible value expected by the licensor.